Beneficial effects of gonadotropin-releasing hormone analogue treatment on positive and negative symptoms of schizophrenia: a case report
Soreni, N.; Weizman, A.; Weiss, M.
Journal of Clinical Psychiatry 65(7): 1020-1021
2004
ISSN/ISBN: 0160-6689 PMID: 15291698 Document Number: 580539
Document emailed within 1 workday
Related Documents
Conn, P.M.; Rogers, D.; Seay, S. 1984: Gonadotropin releasing hormone stimulation of gonadotropin release from the pituitary regulation of cell responses and gonadotropin releasing hormone receptors by gonadotropin releasing hormone receptor micro aggregation Journal of Cellular Biochemistry Suppl (8 Part A): 233Bayoglu Tekin, Y.; Dilbaz, B.; Altinbas, S.K.; Dilbaz, S. 2011: Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue Fertility and Sterility 95(2): 492-496
Kahán, Z.; Falkay, G. 1990: Therapeutic use of a gonadotropin releasing hormone analogue in breast cancer Orvosi Hetilap 131(19): 1033-1036
Romerowicz-Misielak, M.; Tabecka-Lonczynska, A.; Koziol, K.; Gilun, P.; Stefanczyk-Krzymowska, S.; Och, W.; Koziorowski, M. 2016: Changes in gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor gene expression after an increase in carbon monoxide concentration in the cavernous sinus of male wild boar and pig crossbread Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 67(3): 431-442
Almond, G.W.; Esbenshade, K.L.; Smith, C.A.; Richards, R.G. 1992: Effects of chronic gonadotropin-releasing hormone agonist treatment on serum luteinizing hormone and testosterone concentrations in boars American Journal of Veterinary Research 53(1): 22-25
Matzkin, H.; Greenstein, A.; Kaver, I.; Braf, Z. 1989: Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience Israel Journal of Medical Sciences 25(7): 388-392
Masahashi, T.; Negoro, Y.; Asai, M.; Suzuki, M.; Noguchi, M.; Nakanishi, M.; Tomita, A. 1992: Bone mineral content in premenopausal women treated with gonadotropin-releasing hormone analogue Nihon Sanka Fujinka Gakkai Zasshi 44(5): 577-580
Bobyntsev, I.I.; Sever'ianova, L.A.; Smakhtin, M.I.; Ktiukov, A.A. 2005: Effect of the intraventricular administration of gonadotropin-releasing hormone analogue on immune response and unspecific resistance in rats Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 91(10): 1176-1181
Möller, H.J. 1995: The psychopathology of schizophrenia: an integrated view on positive symptoms and negative symptoms International Clinical Psychopharmacology 10(Suppl): 57-64
Glick, I.D.; Jacobs, M.; Lieberman, J.; Simpson, G.; Schooler, N.R. 1989: Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 344-347
Zhang, P.; Song, K.; Li, L.; Yukuwa, K.; Kong, B. 2013: Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis Medical Principles and Practice: International Journal of the Kuwait University Health Science Centre 22(5): 480-483
Manetta, L.A.; de Paula Martins, W.; Rosa e Silva, J.úl.C.és.; de Sá Rosa e Silva, A.C.J.; Nogueira, A.ôn.A.; Ferriani, R.A. 2008: Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist Ultrasound in Medicine and Biology 34(12): 1914-1918
Yang, T.S.; Wang, B.C.; Chang, S.P.; Ng, H.T. 1995: Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization Zhonghua Yi Xue Za Zhi 55(6): 452-456
Szilágyi, G.; Szabolcs, I.; Vydra, G.; Góth, M.; Irsy, G. 1984: Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism Acta Medica Hungarica 41(4): 175-183
Fulghesu, A.M.; Lanzone, A.; Guida, C.; Nicoletti, M.C.; Rossi, P.; Le Donne, M.; Caruso, A.; Mancuso, S. 1992: Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. a cross-over study Journal of Reproductive Medicine 37(10): 834-840
Suwa, N. 1985: Symptom structures in schizophrenia--with special reference to negative and positive symptoms Seishin Shinkeigaku Zasshi 87(11): 787-798
Møller, P. 1995: Positive and negative psychotic symptoms in schizophrenia. Clinical significance and benefits in the light of the history of classification Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(20): 2529-2532
Sarkadi, A.; Szabo, S.; Laszy, J.; Ambrus, A.; Szporny, L. 1988: Effects of thyrotropin-releasing hormone and its analogue L-6-ketopiperidine-2-carbonyl-leucyl-L-prolin-amide on behaviour and electroencephalogram Arzneimittel-Forschung 38(8): 1134-1138
Abbas, Q.; Ramzan, Z.; Emad, F.; Rehman, R.U. 2019: Pattern of positive, negative and general psychopathological symptoms among schizophrenia patients at primary care setting: a comparative study JPMA. Journal of the Pakistan Medical Association 69(3): 361-366
Steingold, K.A.; Cedars, M.; Lu, J.K.; Randle, D.; Judd, H.L.; Meldrum, D.R. 1987: Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist Obstetrics and Gynecology 69(3 Part 1): 403-411